07 May 2024
07 May 2024
Total revenues for the quarter saw a substantial decrease to €187.6m from €1.27bn in Q1 2023.
The centre of gravity in the pharmaceutical industry is changing. But one common factor can help make supply chains more comprehensible, resilient and valuable: data
The 600mg long-acting injection is the first injectable treatment for HIV prevention approved in the UK.
The FTC is cracking down on pharma companies filing sham patents in the Orange Book to delay generics competition.
Under their partnership deal, the companies will develop up to ten new cell and gene therapy products.
Cipla USA is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution.
Gossamer is entitled to receive $160m in development reimbursement from Chiesi.
The decision for IBI343 is based on promising data from an ongoing Phase I clinical trial.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
